OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease
Wei‐Ming Su, Xiaojing Gu, Meng Dou, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 11, pp. 954-961
Open Access | Times Cited: 62
Wei‐Ming Su, Xiaojing Gu, Meng Dou, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 11, pp. 954-961
Open Access | Times Cited: 62
Showing 1-25 of 62 citing articles:
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro
Qing-Qing Duan, Han Wang, Wei‐Ming Su, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Qing-Qing Duan, Han Wang, Wei‐Ming Su, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 12
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 12
Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis
Wenlong Zhao, Fang Peng, Chengteng Lai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Wenlong Zhao, Fang Peng, Chengteng Lai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Systematic druggable genome‐wide Mendelian randomization identifies therapeutic targets for sarcopenia
Kang‐Fu Yin, Ting Chen, Xiaojing Gu, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 4, pp. 1324-1334
Open Access | Times Cited: 10
Kang‐Fu Yin, Ting Chen, Xiaojing Gu, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 4, pp. 1324-1334
Open Access | Times Cited: 10
Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine
Xinyue Sun, Bohong Chen, Yi Qi, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Xinyue Sun, Bohong Chen, Yi Qi, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Codonopsis pilosula water extract delays D-galactose-induced aging of the brain in mice by activating autophagy and regulating metabolism
X. J. Wang, Jiachao Kang, Xuechan Li, et al.
Journal of Ethnopharmacology (2024) Vol. 327, pp. 118016-118016
Closed Access | Times Cited: 8
X. J. Wang, Jiachao Kang, Xuechan Li, et al.
Journal of Ethnopharmacology (2024) Vol. 327, pp. 118016-118016
Closed Access | Times Cited: 8
Possible linking and treatment between Parkinson’s disease and inflammatory bowel disease: a study of Mendelian randomization based on gut–brain axis
Beiming Wang, Xiaoyin Bai, Yingmai Yang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Beiming Wang, Xiaoyin Bai, Yingmai Yang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1
Expanding causal genes for Parkinson’s disease via multi-omics analysis
Xiaojing Gu, Wei‐Ming Su, Meng Dou, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Xiaojing Gu, Wei‐Ming Su, Meng Dou, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Mitochondrial dysfunction gene expression, DNA methylation, and inflammatory cytokines interaction activate Alzheimer’s disease: a multi-omics Mendelian randomization study
Xiaoxue Zhang, Wei Meng, Heran Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Xiaoxue Zhang, Wei Meng, Heran Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Multi-omics Mendelian randomization integrating GWAS, eQTL, and mQTL data identified genes associated with breast cancer
Zhihao Zhang
American Journal of Cancer Research (2024) Vol. 14, Iss. 3, pp. 1433-1445
Open Access | Times Cited: 5
Zhihao Zhang
American Journal of Cancer Research (2024) Vol. 14, Iss. 3, pp. 1433-1445
Open Access | Times Cited: 5
Diagnostic and therapeutic value of human serpin family proteins
Sabina Janciauskiene, Urszula Lechowicz, Magdalena Pelc, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116618-116618
Open Access | Times Cited: 5
Sabina Janciauskiene, Urszula Lechowicz, Magdalena Pelc, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116618-116618
Open Access | Times Cited: 5
Identification of Potential Causal Genes for Neurodegenerative Diseases by Mitochondria-Related Genome-Wide Mendelian Randomization
Kang‐Fu Yin, Ting Chen, Xiaojing Gu, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Kang‐Fu Yin, Ting Chen, Xiaojing Gu, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Identification of Drug-Targetable Genes for Eczema and Dermatitis Using Integrated Genomic and Proteomic Approaches
Sha Yang, Jianning Song, Min Deng, et al.
Dermatitis (2025)
Closed Access
Sha Yang, Jianning Song, Min Deng, et al.
Dermatitis (2025)
Closed Access
Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
Zhe Chen, Mimi L.K. Tang, Nan Wang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Zhe Chen, Mimi L.K. Tang, Nan Wang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Identification of Potential Therapeutic Targets for Sensorineural Hearing Loss and Evaluation of Drug Development Potential Using Mendelian Randomization Analysis
Shun Ding, Qiling Tong, Yixuan Liu, et al.
Bioengineering (2025) Vol. 12, Iss. 2, pp. 126-126
Open Access
Shun Ding, Qiling Tong, Yixuan Liu, et al.
Bioengineering (2025) Vol. 12, Iss. 2, pp. 126-126
Open Access
NEK4: prediction of available drug targets and common genetic linkages in bipolar disorder and major depressive disorder
Bin Gong, Chenxu Xiao, Yu Feng, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Bin Gong, Chenxu Xiao, Yu Feng, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Mendelian Randomization and Colocalization Analysis Reveal New Drug Targets for Oral Ulcer: A Mendelian Randomization Analysis
Xiaoyu Zhang, Hui Fan, Xiaoguang Zhang, et al.
Health Science Reports (2025) Vol. 8, Iss. 2
Open Access
Xiaoyu Zhang, Hui Fan, Xiaoguang Zhang, et al.
Health Science Reports (2025) Vol. 8, Iss. 2
Open Access
Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome‐Wide Mendelian Randomization and Colocalization Analysis
Maoxia Fan, Na Li, Li‐Chi Huang, et al.
Cardiovascular Therapeutics (2025) Vol. 2025, Iss. 1
Open Access
Maoxia Fan, Na Li, Li‐Chi Huang, et al.
Cardiovascular Therapeutics (2025) Vol. 2025, Iss. 1
Open Access
Exploring druggable targets and inflammation-mediated pathways in cancer: a Mendelian randomization analysis integrating transcriptomic and proteomic data
Hao Pan, Changqing Jing
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
Hao Pan, Changqing Jing
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
Biomarker identification for Alzheimer’s disease through integration of comprehensive Mendelian randomization and proteomics data
Hui Zhan, Davis Cammann, Jeffrey L. Cummings, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Hui Zhan, Davis Cammann, Jeffrey L. Cummings, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Identification of biomarkers and potential drug targets for esophageal cancer: a Mendelian randomization study
Chengjun Li, Xiaomeng Cui, Mudan Ren, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Chengjun Li, Xiaomeng Cui, Mudan Ren, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Therapeutic Targets for Multiple System Atrophy
D S Fan, Jianhui Dai, Li Zhang, et al.
Research Square (Research Square) (2025)
Closed Access
D S Fan, Jianhui Dai, Li Zhang, et al.
Research Square (Research Square) (2025)
Closed Access
The Application Status and Prospects of the Mendelian Randomization Method in Endometrial Cancer Research
怡 沙
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 2004-2009
Closed Access
怡 沙
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 2004-2009
Closed Access
Genomic and GEO data integration identifies PDGFB as a potential therapeutic target for sepsis
Mingjun Guo, Lei Shu, Zhihui He
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Mingjun Guo, Lei Shu, Zhihui He
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
